ApprovalTrail

Drug · DIN 02436264

FOSAPREPITANT

SINGLE-DOSE VIAL

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since August 25, 2015.
Drug Identification Number (DIN)
02436264
Company (DIN owner)
Apotex Inc.Toronto, Ontario, Canada
Schedule
Prescription
Dosage form
Powder For Solution
Route
Intravenous
Therapeutic class (ATC)
Other antiemetics A04AD
Class
Human
Record last updated
August 7, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)150 MGVIAL

Notices of Compliance

Health Canada approvals that name this DIN.